Publication

Avutometinib plus defactinib in recurrent low-grade serous ovarian cancer: a subgroup analysis of ENGOT-OV60/GOG-3052/ RAMP 201 part A

Banerjee, S.
; 
Van Nieuwenhuysen, E.
; 
Santin, A.
; 
Ring, K.
; 
Colombo, N.
; 
Thaker, P.
; 
Prendergast, E.
; 
Clamp, Andrew
; 
Ray-Coquard, I.
; 
Chon, H. S.
... show 10 more
Citations
Altmetric:
Abstract
Authors
Banerjee, S.
Van Nieuwenhuysen, E.
Santin, A.
Ring, K.
Colombo, N.
Thaker, P.
Prendergast, E.
Clamp, Andrew
Ray-Coquard, I.
Chon, H. S.
Moore, K.
Salinas, E.
Rose, P.
O'Malley, D.
Oaknin, A.
Monk, B.
Holloway, R.
Newman, G.
Moroney, J.
Van Gorp, T.
Kalbacher, E.
Gennigens, C.
Wojtynek, N.
Lustgarten, S.
Grisham, R.
Affiliation
The Christie NHS Foundation Trust and University of Manchester, NCRI, Manchester, United Kingdom
Description
Date
2024
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Banerjee S, Van Nieuwenhuysen E, Santin A, Ring K, Colombo N, Thaker P, et al. Avutometinib plus defactinib in recurrent low-grade serous ovarian cancer: A subgroup analysis of ENGOT-OV60/GOG-3052/ RAMP 201 Part A. GYNECOLOGIC ONCOLOGY. 2024 NOV;190:S55-S6. PubMed PMID: WOS:001330731400075. English.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/627374
Embedded videos